Johao Escobar

Dec 6, 2024 | digitalcommons.library.tmc.edu | Johao Escobar |Mario Rodriguez |Eric Bates |Umair Khalid

AbstractDual antiplatelet therapy (DAPT) combines two antiplatelet agents to decrease the risk of thrombotic complications associated with atherosclerotic cardiovascular diseases. Emerging data about the duration of DAPT is being published continuously. New approaches are trying to balance the time, benefits, and risks for patients taking DAPT for established cardiovascular diseases.

Jul 18, 2023 | mdpi.com | Johao Escobar |Mario Rodriguez |Eric Bates |Umair Khalid

Open AccessReviewbyHafeez Ul Hassan Virk 1, Johao Escobar 2, Mario Rodriguez 3, Eric R. Bates 4, Umair Khalid 5, Hani Jneid 6, Yochai Birnbaum 5, Glenn N. Levine 5, Sidney C.